Literature DB >> 24292379

CYP3A4 overexpression enhances apoptosis induced by anticancer agent imidazoacridinone C-1311, but does not change the metabolism of C-1311 in CHO cells.

Monika Pawłowska1, Ewa Augustin1, Zofia Mazerska1.   

Abstract

AIM: To examine whether CYP3A4 overexpression influences the metabolism of anticancer agent imidazoacridinone C-1311 in CHO cells and the responses of the cells to C-1311.
METHODS: Wild type CHO cells (CHO-WT), CHO cells overexpressing cytochrome P450 reductase (CPR) [CHO-HR] and CHO cells coexpressing CPR and CYP3A4 (CHO-HR-3A4) were used. Metabolic transformation of C-1311 and CYP3A4 activity were measured using RP-HPLC. Flow cytometry analyses were used to examine cell cycle, caspase-3 activity and cell apoptosis. The expression of pH 6.0-dependent β-galactosidase (SA-β-gal) was studied to evaluate accelerated senescence. ROS generation was analyzed with CM-H2 DCFDA staining.
RESULTS: CYP3A4 overexpression did not change the metabolism of C-1311 in CHO cells: the levels of all metabolites of C-1311 increased with the exposure time to a similar extent, and the differences in the peak level of the main metabolite M3 were statistically insignificant among the three CHO cell lines. In CHO-HR-3A4 cells, C-1311 effectively inhibited CYP3A4 activity without affecting CYP3A4 protein level. In the presence of C-1311, CHO-WT cells underwent rather stable G2/M arrest, while the two types of transfected cells only transiently accumulated at this phase. C-1311-induced apoptosis and necrosis in the two types of transfected cells occurred with a significantly faster speed and to a greater extent than in CHO-WT cells. Additionally, C-1311 induced ROS generation in the two types of transfected cells, but not in CHO-WT cells. Moreover, CHO-HR-3A4 cells that did not die underwent accelerated senescence.
CONCLUSION: CYP3A4 overexpression in CHO cells enhances apoptosis induced by C-1311, whereas the metabolism of C-1311 is minimal and does not depend on CYP3A4 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292379      PMCID: PMC4075741          DOI: 10.1038/aps.2013.132

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  50 in total

1.  Antitumour imidazoacridone C-1311 induces cell death by mitotic catastrophe in human colon carcinoma cells.

Authors:  Magdalena Hyzy; Przemyslaw Bozko; Jerzy Konopa; Andrzej Skladanowski
Journal:  Biochem Pharmacol       Date:  2005-01-18       Impact factor: 5.858

Review 2.  Cytochrome P450s and other enzymes in drug metabolism and toxicity.

Authors:  F Peter Guengerich
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

3.  Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas.

Authors:  Susanne Haas; Christiane Pierl; Volker Harth; Beate Pesch; Sylvia Rabstein; Thomas Brüning; Yon Ko; Ute Hamann; Christina Justenhoven; Hiltrud Brauch; Hans-Peter Fischer
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

4.  Inhibition of human CYP2B6 by N,N',N''-triethylenethiophosphoramide is irreversible and mechanism-based.

Authors:  Tanja Richter; Matthias Schwab; Michel Eichelbaum; Ulrich M Zanger
Journal:  Biochem Pharmacol       Date:  2004-12-15       Impact factor: 5.858

5.  Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene.

Authors:  Robin E Pearce; Jack P Uetrecht; J Steven Leeder
Journal:  Drug Metab Dispos       Date:  2005-08-31       Impact factor: 3.922

6.  High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation.

Authors:  S Ding; D Yao; B Burchell; C R Wolf; T Friedberg
Journal:  Arch Biochem Biophys       Date:  1997-12-15       Impact factor: 4.013

Review 7.  Mitotic catastrophe as a consequence of chemotherapy.

Authors:  Sylvia Mansilla; Marc Bataller; José Portugal
Journal:  Anticancer Agents Med Chem       Date:  2006-11       Impact factor: 2.505

Review 8.  Caspases: the executioners of apoptosis.

Authors:  G M Cohen
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

9.  Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.

Authors:  J Gjerde; E R Kisanga; M Hauglid; P I Holm; G Mellgren; E A Lien
Journal:  J Chromatogr A       Date:  2005-07-29       Impact factor: 4.759

10.  Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.

Authors:  L M Notley; K H Crewe; P J Taylor; M S Lennard; E M J Gillam
Journal:  Chem Res Toxicol       Date:  2005-10       Impact factor: 3.739

View more
  2 in total

1.  Utilizing Genome-Wide mRNA Profiling to Identify the Cytotoxic Chemotherapeutic Mechanism of Triazoloacridone C-1305 as Direct Microtubule Stabilization.

Authors:  Jarosław Króliczewski; Sylwia Bartoszewska; Magdalena Dudkowska; Dorota Janiszewska; Agnieszka Biernatowska; David K Crossman; Karol Krzymiński; Małgorzata Wysocka; Anna Romanowska; Maciej Baginski; Michal Markuszewski; Renata J Ochocka; James F Collawn; Aleksander F Sikorski; Ewa Sikora; Rafal Bartoszewski
Journal:  Cancers (Basel)       Date:  2020-04-02       Impact factor: 6.639

2.  Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs' Cytotoxicity, Metabolism and Cellular Response.

Authors:  Monika Pawłowska; Anna Kwaśniewska; Zofia Mazerska; Ewa Augustin
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.